Schedule 13G ownership disclosure

Kura Oncology Inc

Common Stock, par value $0.0001 per share · CUSIP: 50127T109

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Armistice Capital, LLC

    Shares: 6,572,000.00 · Class: 7.59%

  • Steven Boyd

    Shares: 6,572,000.00 · Class: 7.59%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-002262
Form type
SCHEDULE 13G/A
Filer
ARMISTICE CAPITAL, LLC
CIK
CIK 1601086
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub